Clinical trial NCT03137511: Optimizing Access to Care Through New Technologies: a Randomized Study Evaluating the Impact of Telephone Contact and the Sending by the General Practitioner of Suspicious Lesions Melanoma Photographs Taken With a Smartphone, on the Time Limit to the Consultation With a Dermatologist
Official title: Optimizing Access to Care Through New Technologies: a Randomized Study Evaluating the Impact of Telephone Contact and the Sending by the General Practitioner of Suspicious Lesions Melanoma Photographs Taken With a Smartphone, on the Time Limit to the Consultation With a Dermatologist
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Patients at Risk for Melanoma
Keywords: Public Health
General Medicine
Dermatology
Lead sponsor: Nantes University Hospital
Sponsor class: OTHER
First posted: 2017-05-02
Enrollment: 270
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: yes
Allocation: RANDOMIZED
Intervention model: PARALLEL
Intervention model description: Cluster randomization of MGs corresponding to their exercise sites
Primary purpose: PREVENTION

Brief summary: Early detection of melanoma showed an impact on the thickness of the lesions at the time of diagnosis. One challenge is to improve the modalities.

Decrease the rate of non-compliant patients among patients referred to the dermatologist for a suspicious lesion (patients who will never go to the consultation), and reduce the time interval between the first identification of the lesion and the excision allowing the diagnosis are major issues.

Direct contact between the general practitioner (GP) and the dermatologist would probably make it possible to shorten the care pathway of patients with lesions justifying excision.

The objective is to evaluate whether contacting the dermatologist directly by telephone and e-mailing the photograph of a suspicious melanoma lesion can significantly reduce the time required for access to the consultation for the following patients: (a) referred for a suspicious lesion of melanoma by the GP (b) and having a sufficiently suspicious lesion of melanoma so that the dermatologist conclude at the need for excision (true positives).

Expected results: The procedure should shorten the care pathway for patients with melanoma and decrease the proportion of patients who do not consult the dermatologist when they were referred ("non-observing patients").

This should facilitate the identification of thinner lesions. The benefit for the patient is then direct with a survival at 5 years higher.

In public health terms, it is expected a benefit as better optimization of resources. In a situation of shortage of professionals, access to the dermatologist should be optimized by optimizing emergency access for patients who require it.


Eligibility criteria: Inclusion Criteria:

Patients:

* Consulting a general practitioner participating in the study,
* Having a suspicious cutaneous lesion of melanoma according to the MG,
* Referred to a dermatologist who agreed to participate in the study,
* \> = 18 years of age, with written informed consent,
* Affiliated to a social security scheme

Exclusion Criteria:

Patients:

* Consulting a general practitioner who does not participate in the study,
* Having no suspect melanoma lesion according to MG,
* Referred to the dermatologist for symptoms or pathologies unrelated to a suspicion of melanoma
* Wishing to consult a dermatologist who refused to participate in the study,
* Refusing the transmission by mail of 2 anonymised photos,
* \<18 years of age, or with no written informed consent.
* Major under tutelage, under curatorship

Primary outcomes:
measure: Time limit for consultation general practitioner / dermatologist, patients having a sufficiently suspicious lesion of melanoma
timeFrame: 12 months
Secondary outcomes:
measure: Time limit for consultation general practitioner / dermatologist, patients NOT having a sufficiently suspicious lesion of melanoma
timeFrame: 12 months
measure: "Non-observing" patients between the 2 randomization groups
timeFrame: 12 months
Other outcomes:
Locations:
city: Nantes
country: France
facility: University Hospital
Study officials:
References: